Mushroom-Laced Candy Recall Highlights F.D.A.’s Limited Safety Role
Posted inCenters for Disease Control and Prevention Diamond Shruumz (Prophet Premium Blends LLC) Dietary Supplements and Herbal Remedies Drugs (Pharmaceuticals) Food Food and Drug Administration Food Contamination and Poisoning Poisoning and Poisons Psilocybin Mushrooms Regulation and Deregulation of Industry

Mushroom-Laced Candy Recall Highlights F.D.A.’s Limited Safety Role

More than 150 people were sickened from products sold at smoke and vape shops, providing evidence of the lax regulation of new food items.
F.D.A. Declines to Approve MDMA Therapy, Seeking More Study
Posted inClinical Trials Drug Enforcement Administration Drugs (Pharmaceuticals) Ecstasy (Drug) Food and Drug Administration LSD (Lysergic Acid Diethylamide) Lykos Therapeutics Mental Health and Disorders Post-Traumatic Stress Disorder Psilocybin Mushrooms Psychedelic and Hallucinogenic Drugs Psychology and Psychologists Regulation and Deregulation of Industry Research Therapy and Rehabilitation Veterans

F.D.A. Declines to Approve MDMA Therapy, Seeking More Study

The agency said there was insufficient data to allow the use of a treatment for PTSD that involves the drug known as Ecstasy, according to the company seeking approval.
Veterans and Lawmakers Lobby for Approval of MDMA Therapy
Posted inBergman, Jack (1947- ) Clinical Trials Depression (Mental) Drugs (Pharmaceuticals) Ecstasy (Drug) Food and Drug Administration House of Representatives Institute for Clinical and Economic Review LSD (Lysergic Acid Diethylamide) Lykos Therapeutics Mental Health and Disorders Post-Traumatic Stress Disorder Psilocybin Mushrooms Psychedelic and Hallucinogenic Drugs Psychiatry and Psychiatrists Regulation and Deregulation of Industry Research Therapy and Rehabilitation Veterans

Veterans and Lawmakers Lobby for Approval of MDMA Therapy

The F.D.A. is poised to rule on the therapeutic use of the club drug Ecstasy, a potential watershed moment in the nascent field of psychedelic medicine.